SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OncoGenex Pharmaceuticals Inc. Announces Initiation of a Phase 3 Trial for Custirsen in Advanced Non-Small Cell Lung Cancer